Skip to main content
. 2020 Sep 2;12(9):840. doi: 10.3390/pharmaceutics12090840

Figure 2.

Figure 2

Antibacterial activity of WRL3 and antibiotics. (A) SEM images of the in vitro methicillin-resistant S. aureus (MRSA)-biofilm inhibition at indicated VWR3 concentrations compared to the control cells; (B) Photos of wound regions of approximately 1 cm2 on the back of MRSA-infected mice and treated with MET (methicillin), VAN (vancomycin), WRL3, CRO (ceftriaxone), or WRL3 and CRO at 3, 7, 14, and 21 days post-MRSA infection. “Fatal” indicates no mice survival. From [41] with permission from the American Chemical Society© Copyright 2020.